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T.L. Forbes, Associate Editor, Journal of Vascular Surgery
Division of Vascular Surgery, London Health Sciences Centre & Western University, 800 Commissioners Road East, Room E2-119, London, ON N6A 5W9, CanadaThe evidence for reducing the diameter threshold for
elective intervention in asymptomatic women with
abdominal aortic aneurysms (AAAs) to 5.0 cm is that (i)
women have signiﬁcantly narrower aortas (compared with
men), so that the diameter of an AAA requiring intervention
should be smaller; (ii) comorbidities (risks) increase with
age, meaning it is better to intervene at an earlier age (size)
in order to reduce operative mortality; (iii) if rupture occurs,
women face higher mortality rates than men; and (iv) data
from randomised and nonrandomised studies suggest that
women rupture their AAAs at slightly smaller diameters
than men (5.0 cm). Advocates for reducing the diameter
threshold to 5 cm concede that women incur higher peri-
operative mortality rates (compared with men), but that
mortality rates after elective open repair (OR) or endovas-
cular aneurysm repair (EVAR) are several magnitudes lower
than the mortality associated with the treatment of
ruptured AAA.
Advocates for leaving diameter thresholds unchanged
argue that while some of the points (raised above) have
evidential support, there are important confounding issues:
(i) women were under-represented in the trials, which
were never powered to perform subgroup analyses
regarding sex; (ii) data suggesting that women may be
rupturing at slightly smaller aortic diameters are statisti-
cally weak (small number of events in a small number of
patients) and might represent a type II statistical error; (iii)
even if women did rupture at slightly smaller aortic di-
ameters, any potential beneﬁt through early intervention
would be negated by the twofold excess mortality rate
following elective EVAR or OR.So which side wins? One (undiscussed) issue remains the
historical selection of 5.5 cm as the diameter threshold for
intervening in the ﬁrst place. The choice of 5.5 cm was not
based upon science, but upon the equipoise of those sur-
geons who were prepared to randomise patients with AAAs
of 5 cm, 5.5 cm, or 6.0 cm in diameter. At the time, the
consensus was 5.5 cm, but this “one size ﬁts all” mea-
surement was never designed to deliver optimal diameter
thresholds for men as opposed to women. Moreover,
because some European and US guidelines now tacitly
support “consideration” for elective interventions in women
with 5.0e5.5-cm diameter AAAs, the vox populi interpre-
tation is likely to be that this is reasonable.
However, there are important caveats for those surgeons/
interventionists who advocate elective interventions in
women with 5.0-cm AAAs. First, they need to be very clear
about which diameter measurement method they are using.
Those measuring inner-to-inner AAA diameter using ultra-
sound will document diameters 4e5 mm less than if the
outer-to-outer measurement method is used. However, if
computed tomography is used to measure an outer-to-outer
diameter, this will then be 4e5 mm greater than the corre-
sponding ultrasound measurement (and up to 1 cm greater
than any inner-to-inner ultrasound-derived measurement).
Second (and at the very least), there should be no talk of
“time bombs” during the consent process, and women with
5-cm AAAs under consideration for surgery need to be
informed about the underlying controversy. Put simply,
there should be no rush towards performing EVAR/OR in
women with 5-cm AAAs. Like it or not, they do face a higher
morbidity/mortality (than men) and it is incumbent on the
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ment has been performed, whether comorbidities can be
optimised, and even whether he/she may be the best
person to undertake any planned intervention. Finally, while
we can all hope that industry comes up with better endo-
vascular technologies to enable a greater proportion of
women to undergo EVAR (which they will), there is a very
real risk that “bending the rules” to offer elective EVAR towomen with 5-cm AAAs outside the manufacturer’s ‘in-
dications for use’ (IFU) can be deleterious to the patient
(who faces a higher risk of endoleak and late conversion)
and possibly the treating clinician. Surgeons/in-
terventionists should be aware that in many countries, if
they perform an EVAR outside the manufacturer’s IFU, they
absolve the stent manufacturing company from any future
medico-legal responsibility and assume this themselves.*Corresponding author.
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